Turn Therapeutics (TTRX) Non-cash Items (2024 - 2026)

Turn Therapeutics' quarterly Non-cash Items came in at $1.6 million in Q1 2026, down 79.79% quarter-over-quarter from $8.1 million in Q4 2025.

Turn Therapeutics has reported Non-cash Items for 3 years, with the latest figure at $1.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (changed N/A YoY), and the FY2025 full-year result was $8.1 million, up 108.3% from the prior year.
  • Non-cash Items for Q1 2026 stood at $1.6 million, down from $8.1 million in the prior quarter.
  • The five-year high for Non-cash Items was $8.1 million in Q4 2025, with the low at $1.6 million in Q3 2025.
  • Average Non-cash Items over 3 years is $3.8 million, with a median of $2.8 million recorded in 2024.
  • Peak annual rise in Non-cash Items reached 108.3% in 2025, while the deepest fall reached 108.3% in 2025.
  • Tracing TTRX's Non-cash Items over 3 years: stood at $3.9 million in 2024, then soared by 108.3% to $8.1 million in 2025, then sank by 79.79% to $1.6 million in 2026.
  • The last three Non-cash Items figures came in at $1.6 million (Q1 2026), $8.1 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Turn Therapeutics 188.06 Mn 188.06 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.63 Mn
Mar 31, 2026 1.63 Mn
Dec 31, 2025 8.08 Mn
Dec 31, 2025 8.08 Mn
Sep 30, 2025 1.63 Mn
Sep 30, 2025 1.63 Mn
Dec 31, 2024 3.88 Mn
Dec 31, 2024 3.88 Mn